OptimizeRx Corp — Director's Dealing 2022

Sep 30, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2022-09-29

Reporting Person: Vos Ellen O'Connor (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-29	Common Stock	M	334	—	Acquired	33724	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-09-29	Restricted Stock Units	$	M	334	Disposed		Common Stock (334.0)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: On September 29, 2021 the reporting person was granted 334 restricted stock units which vested in full on September 29, 2022.